Zelira Therapeutics Ltd has released a press release.
Zelda Collaborates with Emerald Clinics
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Response to ASX Price and Volume Query
- Zelda Granted Approval for Opioid Reduction Trial
- March 2019 Quarterly Report
- Zelda Partners with Ilera HealthCare
- Aus Patent For Novel Prognostic Marker for Breast Cancer
Later from Zelira Therapeutics
- June 2019 Quarterly Report
- Zeldas Autism Observational Study Recruits 100th Participant
- Zelda to merge with US-based Ilera Therapeutics
- September 2019 Quarterly Report
- Zeldas Phase II Insomnia Clinical Trial Fully Enrolled
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics